Literature DB >> 10746816

Endothelial dysfunction in patients with heart failure: relationship to disease severity.

A J Bank1, P C Lee, S H Kubo.   

Abstract

BACKGROUND: Heart failure is associated with abnormal endothelium-dependent vasodilation. However, the relationship of this abnormality to heart failure severity has not been well defined. METHODS AND
RESULTS: We used strain-gauge plethysmography to assess forearm blood flow (FBF) responses to endothelium-dependent, endothelium-independent, and reactive hyperemic stimuli in normal subjects (n = 29) and in patients with mild (n = 26) and severe (n = 41) heart failure. FBF responses to intra-arterial methacholine (0.3, 1.5, 3.0 microg/min) were significantly (P < .005) and similarly reduced in patients with mild (2.8 +/- 0.4, 5.9 +/- 0.7, and 7.7 +/- 1.1 mL/min/dL) and severe (2.7 +/- 0.4, 5.4 +/- 0.7, and 6.9 +/- 0.9) heart failure compared with normal subjects (4.5 +/- 0.4, 9.4 +/- 1.0, and 12.0 +/- 1.1). FBF responses to nitroprusside (1, 5, 10 microg/min) were significantly reduced in mild (2.4 +/- 0.3, 6.7 +/- 1.1, and 11.9 +/- 2.0, P < .05) and severe (1.9 +/- 0.2, 5.1 +/- 0.5, and 7.3 +/- 0.9, P < .001) heart failure groups compared with normal subjects (3.8 +/- 0.5, 10.8 +/- 1.2, and 14.9 +/- 1.2). However, FBF responses were reduced to a greater extent (P < .001) in mild heart failure compared with severe heart failure. Peak reactive hyperemia was significantly impaired only in severe heart failure. There was no correlation between methacholine responses and ejection fraction, maximum oxygen consumption, wedge pressure, or serum norepinephrine.
CONCLUSION: Impaired endothelium-dependent vasodilation is present and near maximum in mild heart failure. Endothelial dysfunction may be an early finding in human heart failure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10746816     DOI: 10.1016/s1071-9164(00)00009-9

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  11 in total

1.  Effects of continuous flow left ventricular assist device support on microvascular endothelial function.

Authors:  Xiaoying Lou; Danielle L Templeton; Ranjit John; Donald R Dengel
Journal:  J Cardiovasc Transl Res       Date:  2011-09-20       Impact factor: 4.132

2.  Elastic properties of peripheral arteries in heart failure patients in comparison with normal subjects.

Authors:  Chengyu Liu; Dingchang Zheng; Lina Zhao; Peng Li; Bin Li; Alan Murray; Changchun Liu
Journal:  J Physiol Sci       Date:  2013-03-22       Impact factor: 2.781

Review 3.  Soluble guanylate cyclase: a potential therapeutic target for heart failure.

Authors:  Mihai Gheorghiade; Catherine N Marti; Hani N Sabbah; Lothar Roessig; Stephen J Greene; Michael Böhm; John C Burnett; Umberto Campia; John G F Cleland; Sean P Collins; Gregg C Fonarow; Phillip D Levy; Marco Metra; Bertram Pitt; Piotr Ponikowski; Naoki Sato; Adriaan A Voors; Johannes-Peter Stasch; Javed Butler
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

4.  Beneficial Effects of Angiotensin-(1-7) on CD34+ Cells From Patients With Heart Failure.

Authors:  Colleen T Cole-Jeffrey; Carl J Pepine; Michael J Katovich; Maria B Grant; Mohan K Raizada; Sugata Hazra
Journal:  J Cardiovasc Pharmacol       Date:  2018-03       Impact factor: 3.105

5.  Peripheral endothelial dysfunction is a novel risk factor for systolic dysfunction and heart failure progression.

Authors:  Riad Taher; Jaskanwal D Sara; Takumi Toya; Barry A Borlaug; Lilach O Lerman; Amir Lerman
Journal:  Int J Cardiol Heart Vasc       Date:  2020-07-23

6.  Altered left ventricular-arterial coupling precedes pump dysfunction in early heart failure.

Authors:  Sumanth D Prabhu
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

7.  Deteriorated function of cutaneous microcirculation in chronic congestive heart failure.

Authors:  Marie-Louise Edvinsson; Erik Uddman; Sven E Andersson
Journal:  J Geriatr Cardiol       Date:  2011-06       Impact factor: 3.327

8.  Combined Angiotensin Receptor-Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure.

Authors:  Rishi K Trivedi; David J Polhemus; Zhen Li; Daniel Yoo; Hiroshi Koiwaya; Amy Scarborough; Traci T Goodchild; David J Lefer
Journal:  J Am Heart Assoc       Date:  2018-03-03       Impact factor: 5.501

9.  Effect of Xanthine Oxidase Inhibition on Arterial Stiffness in Patients With Chronic Heart Failure.

Authors:  Manal M Alem; Abdullah M Alshehri; Peter Mb Cahusac; Matthew R Walters
Journal:  Clin Med Insights Cardiol       Date:  2018-06-05

10.  Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.

Authors:  David M Smadja; Coralie L Guerin; Richard Chocron; Nader Yatim; Jeremy Boussier; Nicolas Gendron; Lina Khider; Jérôme Hadjadj; Guillaume Goudot; Benjamin Debuc; Philippe Juvin; Caroline Hauw-Berlemont; Jean-Loup Augy; Nicolas Peron; Emmanuel Messas; Benjamin Planquette; Olivier Sanchez; Bruno Charbit; Pascale Gaussem; Darragh Duffy; Benjamin Terrier; Tristan Mirault; Jean-Luc Diehl
Journal:  Angiogenesis       Date:  2020-05-27       Impact factor: 10.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.